<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 21 - FOOD AND DRUGS</title></head><body>
<span style="font-weight:bold;font-size:12pt;">21 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2007 Edition</span><br/>
<span style="font-size:10pt">Title 21 - FOOD AND DRUGS</span><br/>
<span style="font-size:10pt">CHAPTER 9 - FEDERAL FOOD, DRUG, AND COSMETIC ACT</span><br/>
<span style="font-size:10pt">SUBCHAPTER IX - MISCELLANEOUS</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:21_-ch9-scIX currentthrough:20080108 documentPDFPage:360 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX -->
<!-- itemsortkey:210AALK -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS -->
<!-- field-start:structuralhead -->
<h3 class="subchapter-head">SUBCHAPTER IX&mdash;MISCELLANEOUS</h3>
<!-- field-end:structuralhead -->

<!-- documentid:21_391  usckey:210000000039100000000000000000000 currentthrough:20080108 documentPDFPage:360 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 391 -->
<!-- itemsortkey:210AALL -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 391 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;391. Separability clause</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">If any provision of this chapter is declared unconstitutional, or the applicability thereof to any person or circumstances is held invalid, the constitutionality of the remainder of the chapter and the applicability thereof to other persons and circumstances shall not be affected thereby.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;901, 52 Stat. 1059.)</p>
<!-- field-end:sourcecredit -->

<!-- documentid:21_392  usckey:210000000039200000000000000000000 currentthrough:20080108 documentPDFPage:360 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 392 -->
<!-- itemsortkey:210AALM -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 392 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;392. Exemption of meats and meat food products</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Law determinative of exemption</h4>
<p class="statutory-body">Meats and meat food products shall be exempt from the provisions of this chapter to the extent of the application or the extension thereto of the Meat Inspection Act, approved March 4, 1907, as amended [21 U.S.C. 601 et seq.].</p>
<h4 class="subsection-head">(b) Laws unaffected</h4>
<p class="statutory-body">Nothing contained in this chapter shall be construed as in any way affecting, modifying, repealing, or superseding the provisions of section 351 of Public Health Service Act [42 U.S.C. 262] (relating to viruses, serums, toxins, and analogous products applicable to man); the virus, serum, toxin, and analogous products provisions, applicable to domestic animals, of the Act of Congress approved March 4, 1913 (37 Stat. 832&ndash;833) [21 U.S.C. 151 et seq.]; the Filled Cheese Act of June 6, 1896 (U.S.C., 1934 ed., title 26, ch. 10), the Filled Milk Act of March 4, 1923 [21 U.S.C. 61 et seq.]; or the Import Milk Act of February 15, 1927 [21 U.S.C. 141 et seq.].</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;902(b), (c), 52 Stat. 1059; Pub. L. 90&ndash;399, &sect;107, July 13, 1968, 82 Stat. 353.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The Meat Inspection Act, approved March 4, 1907, as amended, referred to in subsec. (a), is act Mar. 4, 1907, ch. 2907, titles I to IV, as added Dec. 15, 1967, Pub. L. 90&ndash;201, 81 Stat. 584, which are classified generally to subchapters I to IV (&sect;601 et seq.) of chapter 12 of this title. For complete classification of this Act to the Code, see Short Title note set out under section 601 of this title and Tables.</p>
<p class="note-body">Act of March 4, 1913, referred to in subsec. (b), is act Mar. 4, 1913, ch. 145, 37 Stat. 828, as amended. The provisions of such act referred to relating to viruses, etc., applicable to domestic animals, are contained in the eighth paragraph under the heading &ldquo;Bureau of Animal Industry&rdquo;, 37 Stat. 832, as amended, popularly known as the Virus-Serum-Toxin Act, which is classified generally to chapter 5 (&sect;151 et seq.) of this title. For complete classification of this Act to the Code, see Short Title note set out under section 151 of this title and Tables.</p>
<p class="note-body">The Filled Cheese Act of June 6, 1896 (U.S.C., 1934 ed., title 26, ch. 10), referred to in subsec. (b), is act June 6, 1896, ch. 337, 29 Stat. 253, as amended, which had been classified to chapter 10 (&sect;1000 et seq.) of Title 26, Internal Revenue, and included as chapter 17 (&sect;2350 et seq.) of Title 26, Internal Revenue Code of 1939. Such chapter 17 was covered by section 4831 et seq. of Title 26, Internal Revenue Code, prior to the repeal of section 4831 et seq. of Title 26 by Pub. L. 93&ndash;490, &sect;3(a)(1), Oct. 26, 1974, 88 Stat. 1466.</p>
<p class="note-body">The Filled Milk Act of March 4, 1923, referred to in subsec. (b), is act Mar. 4, 1923, ch. 262, 42 Stat. 1486, as amended, which is classified generally to chapter 3 (&sect;61 et seq.) of this title. For complete classification of this Act to the Code, see Short Title note set out under section 61 of this title and Tables.</p>
<p class="note-body">The Import Milk Act of February 15, 1927, referred to in subsec. (b), is act Feb. 15, 1927, ch. 155, 44 Stat. 1101, as amended, which is classified generally to subchapter IV (&sect;141 et seq.) of chapter 4 of this title. For complete classification of this Act to the Code, see Short Title note set out under section 141 of this title and Tables.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:codification-note -->
<h4 class="note-head">Codification</h4>
<p class="note-body">Subsecs. (a) and (b) of this section comprise respectively subsecs. (b) and (c) of section 902 of act June 25, 1938. Subsecs. (a) and (d) of section 902 of act June 25, 1938, which prescribed the effective date of this chapter and made appropriations available, are set out as notes under section 301 of this title and this section, respectively.</p>
<!-- field-end:codification-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1968&mdash;Subsec. (b). Pub. L. 90&ndash;399 substituted &ldquo;section 262 of title 42 (relating to viruses, serums, toxins, and analogous products applicable to man)&rdquo; for &ldquo;the virus serum, and toxin Act of July 1, 1902&rdquo; and inserted reference to &ldquo;the virus, serum, toxin, and analogous products provisions, applicable to domestic animals, of the Act of Congress approved March 4, 1913&rdquo;.</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1968 Amendment</h4>
<p class="note-body">Amendment by Pub. L. 90&ndash;399 effective on first day of thirteenth calendar month after July 13, 1968, see section 108(a) of Pub. L. 90&ndash;399, set out as an Effective Date and Transitional Provisions note under section 360b of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Availability of Appropriations</h4>
<p class="note-body">Section 902(d) of act June 25, 1938, provided that: &ldquo;In order to carry out the provisions of this Act which take effect [see section 902(a) of act June 25, 1938, set out as an Effective Date note under section 301 of this title] prior to the repeal of the Food and Drugs Act of June 30, 1906, as amended [sections 1 to 15 of this title], appropriations available for the enforcement of such Act of June 30, 1906, are also authorized to be made available to carry out such provisions.&rdquo;</p>
<!-- field-end:miscellaneous-note -->
<!-- field-end:notes -->

<!-- documentid:21_393  usckey:210000000039300000000000000000000 currentthrough:20080108 documentPDFPage:360 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 393 -->
<!-- itemsortkey:210AALN -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 393 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;393. Food and Drug Administration</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">There is established in the Department of Health and Human Services the Food and Drug Administration (hereinafter in this section referred to as the &ldquo;Administration&rdquo;).</p>
<h4 class="subsection-head">(b) Mission</h4>
<p class="statutory-body">The Administration shall&mdash;</p>
<p class="statutory-body-1em">(1) promote the public health by promptly and efficiently reviewing clinical research and taking appropriate action on the marketing of regulated products in a timely manner;</p>
<p class="statutory-body-1em">(2) with respect to such products, protect the public health by ensuring that&mdash;</p>
<p class="statutory-body-2em">(A) foods are safe, wholesome, sanitary, and properly labeled;</p>
<p class="statutory-body-2em">(B) human and veterinary drugs are safe and effective;</p>
<p class="statutory-body-2em">(C) there is reasonable assurance of the safety and effectiveness of devices intended for human use;</p>
<!-- PDFPage:361 --><p class="statutory-body-2em">(D) cosmetics are safe and properly labeled; and</p>
<p class="statutory-body-2em">(E) public health and safety are protected from electronic product radiation;</p>
<br class="Q04" />
<p class="statutory-body-1em">(3) participate through appropriate processes with representatives of other countries to reduce the burden of regulation, harmonize regulatory requirements, and achieve appropriate reciprocal arrangements; and</p>
<p class="statutory-body-1em">(4) as determined to be appropriate by the Secretary, carry out paragraphs (1) through (3) in consultation with experts in science, medicine, and public health, and in cooperation with consumers, users, manufacturers, importers, packers, distributors, and retailers of regulated products.</p>
<h4 class="subsection-head">(c) Interagency collaboration</h4>
<p class="statutory-body">The Secretary shall implement programs and policies that will foster collaboration between the Administration, the National Institutes of Health, and other science-based Federal agencies, to enhance the scientific and technical expertise available to the Secretary in the conduct of the duties of the Secretary with respect to the development, clinical investigation, evaluation, and postmarket monitoring of emerging medical therapies, including complementary therapies, and advances in nutrition and food science.</p>
<h4 class="subsection-head">(d) Commissioner</h4>
<h4 class="paragraph-head">(1) Appointment</h4>
<p class="statutory-body-1em">There shall be in the Administration a Commissioner of Food and Drugs (hereinafter in this section referred to as the &ldquo;Commissioner&rdquo;) who shall be appointed by the President by and with the advice and consent of the Senate.</p>
<h4 class="paragraph-head">(2) General powers</h4>
<p class="statutory-body-1em">The Secretary, through the Commissioner, shall be responsible for executing this chapter and for&mdash;</p>
<p class="statutory-body-2em">(A) providing overall direction to the Food and Drug Administration and establishing and implementing general policies respecting the management and operation of programs and activities of the Food and Drug Administration;</p>
<p class="statutory-body-2em">(B) coordinating and overseeing the operation of all administrative entities within the Administration;</p>
<p class="statutory-body-2em">(C) research relating to foods, drugs, cosmetics, and devices in carrying out this chapter;</p>
<p class="statutory-body-2em">(D) conducting educational and public information programs relating to the responsibilities of the Food and Drug Administration; and</p>
<p class="statutory-body-2em">(E) performing such other functions as the Secretary may prescribe.</p>
<h4 class="subsection-head">(e) Technical and scientific review groups</h4>
<p class="statutory-body">The Secretary through the Commissioner of Food and Drugs may, without regard to the provisions of title 5 governing appointments in the competitive service and without regard to the provisions of chapter 51 and subchapter III of chapter 53 of such title relating to classification and General Schedule pay rates, establish such technical and scientific review groups as are needed to carry out the functions of the Administration, including functions under this chapter, and appoint and pay the members of such groups, except that officers and employees of the United States shall not receive additional compensation for service as members of such groups.</p>
<h4 class="subsection-head">(f) Agency plan for statutory compliance</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">Not later than 1 year after November 21, 1997, the Secretary, after consultation with appropriate scientific and academic experts, health care professionals, representatives of patient and consumer advocacy groups, and the regulated industry, shall develop and publish in the Federal Register a plan bringing the Secretary into compliance with each of the obligations of the Secretary under this chapter. The Secretary shall review the plan biannually and shall revise the plan as necessary, in consultation with such persons.</p>
<h4 class="paragraph-head">(2) Objectives of agency plan</h4>
<p class="statutory-body-1em">The plan required by paragraph (1) shall establish objectives and mechanisms to achieve such objectives, including objectives related to&mdash;</p>
<p class="statutory-body-2em">(A) maximizing the availability and clarity of information about the process for review of applications and submissions (including petitions, notifications, and any other similar forms of request) made under this chapter;</p>
<p class="statutory-body-2em">(B) maximizing the availability and clarity of information for consumers and patients concerning new products;</p>
<p class="statutory-body-2em">(C) implementing inspection and postmarket monitoring provisions of this chapter;</p>
<p class="statutory-body-2em">(D) ensuring access to the scientific and technical expertise needed by the Secretary to meet obligations described in paragraph (1);</p>
<p class="statutory-body-2em">(E) establishing mechanisms, by July 1, 1999, for meeting the time periods specified in this chapter for the review of all applications and submissions described in subparagraph (A) and submitted after November 21, 1997; and</p>
<p class="statutory-body-2em">(F) eliminating backlogs in the review of applications and submissions described in subparagraph (A), by January 1, 2000.</p>
<h4 class="subsection-head">(g) Annual report</h4>
<p class="statutory-body">The Secretary shall annually prepare and publish in the Federal Register and solicit public comment on a report that&mdash;</p>
<p class="statutory-body-1em">(1) provides detailed statistical information on the performance of the Secretary under the plan described in subsection (f) of this section;</p>
<p class="statutory-body-1em">(2) compares such performance of the Secretary with the objectives of the plan and with the statutory obligations of the Secretary; and</p>
<p class="statutory-body-1em">(3) identifies any regulatory policy that has a significant negative impact on compliance with any objective of the plan or any statutory obligation and sets forth any proposed revision to any such regulatory policy.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;903, as added Pub. L. 100&ndash;607, title V, &sect;503(a), Nov. 4, 1988, 102 Stat. <!-- PDFPage:362 -->3121; amended Pub. L. 100&ndash;690, title II, &sect;2631, Nov. 18, 1988, 102 Stat. 4244; Pub. L. 105&ndash;115, title IV, &sect;&sect;406, 414, Nov. 21, 1997, 111 Stat. 2369, 2377.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The provisions of title 5 governing appointments in the competitive service, referred to in subsec. (e), are classified generally to section 3301 et seq. of Title 5, Government Organization and Employees.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:codification-note -->
<h4 class="note-head">Codification</h4>
<p class="note-body">Another section 903 of the Federal Food, Drug, and Cosmetic Act was renumbered section 904 and is classified to section 394 of this title.</p>
<!-- field-end:codification-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1997&mdash;Subsec. (b). Pub. L. 105&ndash;115, &sect;406(a)(2), added subsec. (b). Former subsec. (b) redesignated (d).</p>
<p class="note-body">Subsec. (c). Pub. L. 105&ndash;115, &sect;414, added subsec. (c). Former subsec. (c) redesignated (e).</p>
<p class="note-body">Subsecs. (d), (e). Pub. L. 105&ndash;115, &sect;406(a)(1), redesignated subsecs. (b) and (c) as (d) and (e), respectively.</p>
<p class="note-body">Subsecs. (f), (g). Pub. L. 105&ndash;115, &sect;406(b), added subsecs. (f) and (g).</p>
<p class="note-body">1988&mdash;Subsec. (b)(2). Pub. L. 100&ndash;690 substituted &ldquo;shall be responsible for executing this chapter and&rdquo; for &ldquo;shall be responsible&rdquo;.</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1997 Amendment</h4>
<p class="note-body">Amendment by Pub. L. 105&ndash;115 effective 90 days after Nov. 21, 1997, except as otherwise provided, see section 501 of Pub. L. 105&ndash;115, set out as a note under section 321 of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-start:effectivedate-note -->
<h4 class="note-head">Effective Date</h4>
<p class="note-body">Section 503(c) of title V of Pub. L. 100&ndash;607 provided that:</p>
<p class="note-body">&ldquo;(1) Except as provided in paragraph (2), the amendments made by this title [enacting this section and amending sections 5315 and 5316 of Title 5, Government Organization and Employees] shall take effect on the date of enactment of this Act [Nov. 4, 1988].</p>
<p class="note-body">&ldquo;(2) Section 903(b)(1) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 393(b)(1)] (as added by subsection (a) of this section) shall apply to the appointments of Commissioners of Food and Drugs made after the date of enactment of this Act.&rdquo;</p>
<!-- field-end:effectivedate-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Office of Minor Use and Minor Species Animal Drug Development</h4>
<p class="note-body">Pub. L. 108&ndash;282, title I, &sect;102(b)(7), Aug. 2, 2004, 118 Stat. 905, provided that: &ldquo;The Secretary of Health and Human Services shall establish within the Center for Veterinary Medicine (of the Food and Drug Administration), an Office of Minor Use and Minor Species Animal Drug Development that reports directly to the Director of the Center for Veterinary Medicine. This office shall be responsible for overseeing the development and legal marketing of new animal drugs for minor uses and minor species. There is authorized to be appropriated to carry out this subsection $1,200,000 for fiscal year 2004 and such sums as may be necessary for each fiscal year thereafter.&rdquo;</p>
<!-- field-end:miscellaneous-note -->
<!-- field-start:regulations-note -->
<h4 class="note-head">Regulations for Sunscreen Products</h4>
<p class="note-body">Section 129 of Pub. L. 105&ndash;115 provided that: &ldquo;Not later than 18 months after the date of enactment of this Act [Nov. 21, 1997], the Secretary of Health and Human Services shall issue regulations for over-the-counter sunscreen products for the prevention or treatment of sunburn.&rdquo;</p>
<!-- field-end:regulations-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">FDA Study of Mercury Compounds in Drugs and Food</h4>
<p class="note-body">Section 413 of Pub. L. 105&ndash;115 provided that:</p>
<p class="note-body">&ldquo;(a) <cap-smallcap>List and Analysis</cap-smallcap>.&mdash;The Secretary of Health and Human Services shall, acting through the Food and Drug Administration&mdash;</p>
<p class="note-body-1em">&ldquo;(1) compile a list of drugs and foods that contain intentionally introduced mercury compounds, and</p>
<p class="note-body-1em">&ldquo;(2) provide a quantitative and qualitative analysis of the mercury compounds in the list under paragraph (1).</p>
<p class="note-body-block">The Secretary shall compile the list required by paragraph (1) within 2 years after the date of enactment of the Food and Drug Administration Modernization Act of 1997 [Nov. 21, 1997] and shall provide the analysis required by paragraph (2) within 2 years after such date of enactment.</p>
<p class="note-body">&ldquo;(b) <cap-smallcap>Study</cap-smallcap>.&mdash;The Secretary of Health and Human Services, acting through the Food and Drug Administration, shall conduct a study of the effect on humans of the use of mercury compounds in nasal sprays. Such study shall include data from other studies that have been made of such use.</p>
<p class="note-body">&ldquo;(c) <cap-smallcap>Study of Mercury Sales.&mdash;</cap-smallcap></p>
<p class="note-body-1em">&ldquo;(1) <cap-smallcap>Study</cap-smallcap>.&mdash;The Secretary of Health and Human Services, acting through the Food and Drug Administration and subject to appropriations, shall conduct, or shall contract with the Institute of Medicine of the National Academy of Sciences to conduct, a study of the effect on humans of the use of elemental, organic, or inorganic mercury when offered for sale as a drug or dietary supplement. Such study shall, among other things, evaluate&mdash;</p>
<p class="note-body-2em">&ldquo;(A) the scope of mercury use as a drug or dietary supplement; and</p>
<p class="note-body-2em">&ldquo;(B) the adverse effects on health of children and other sensitive populations resulting from exposure to, or ingestion or inhalation of, mercury when so used.</p>
<p class="note-body-block-1em">In conducting such study, the Secretary shall consult with the Administrator of the Environmental Protection Agency, the Chair of the Consumer Product Safety Commission, and the Administrator of the Agency for Toxic Substances and Disease Registry, and, to the extent the Secretary believes necessary or appropriate, with any other Federal or private entity.</p>
<p class="note-body-1em">&ldquo;(2) <cap-smallcap>Regulations</cap-smallcap>.&mdash;If, in the opinion of the Secretary, the use of elemental, organic, or inorganic mercury offered for sale as a drug or dietary supplement poses a threat to human health, the Secretary shall promulgate regulations restricting the sale of mercury intended for such use. At a minimum, such regulations shall be designed to protect the health of children and other sensitive populations from adverse effects resulting from exposure to, or ingestion or inhalation of, mercury. Such regulations, to the extent feasible, should not unnecessarily interfere with the availability of mercury for use in religious ceremonies.&rdquo;</p>
<h4 class="note-head">Management Activities Study</h4>
<p class="note-body">Pub. L. 102&ndash;571, title II, &sect;205, Oct. 29, 1992, 106 Stat. 4502, directed Comptroller General to conduct a study of management of activities of the Food and Drug Administration that are related to dietary supplements of vitamins, minerals, herbs, or other similar nutritional substances and submit an interim report to Congress, not later than 6 months after Oct. 29, 1992, with a final report to be submitted not later than 12 months after Oct. 29, 1992.</p>
<h4 class="note-head">Congressional Findings</h4>
<p class="note-body">Section 502 of Pub. L. 100&ndash;607 provided that: &ldquo;Congress finds that&mdash;</p>
<p class="note-body-1em">&ldquo;(1) the public health has been effectively protected by the presence of the Food and Drug Administration during the last eighty years;</p>
<p class="note-body-1em">&ldquo;(2) the presence and importance of the Food and Drug Administration must be guaranteed; and</p>
<p class="note-body-1em">&ldquo;(3) the independence and integrity of the Food and Drug Administration need to be enhanced in order to ensure the continuing protection of the public health.&rdquo;</p>
<!-- PDFPage:363 --><!-- field-end:miscellaneous-note -->
<!-- field-end:notes -->

<!-- documentid:21_393a  usckey:210000000039300000000000a00000000 currentthrough:20080108 documentPDFPage:363 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 393a -->
<!-- itemsortkey:210AALO -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 393a -->
<!-- field-start:head -->
<h3 class="section-head">&sect;393a. Office of Pediatric Therapeutics</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Establishment</h4>
<p class="statutory-body">The Secretary of Health and Human Services shall establish an Office of Pediatric Therapeutics within the Food and Drug Administration.</p>
<h4 class="subsection-head">(b) Duties</h4>
<p class="statutory-body">The Office of Pediatric Therapeutics shall be responsible for coordination and facilitation of all activities of the Food and Drug Administration that may have any effect on a pediatric population or the practice of pediatrics or may in any other way involve pediatric issues, including increasing pediatric access to medical devices.</p>
<h4 class="subsection-head">(c) Staff</h4>
<p class="statutory-body">The staff of the Office of Pediatric Therapeutics shall coordinate with employees of the Department of Health and Human Services who exercise responsibilities relating to pediatric therapeutics and shall include&mdash;</p>
<p class="statutory-body-1em">(1) one or more additional individuals with expertise concerning ethical issues presented by the conduct of clinical research in the pediatric population; and</p>
<p class="statutory-body-1em">(2) one or more additional individuals with expertise in pediatrics as may be necessary to perform the activities described in subsection (b) of this section.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(Pub. L. 107&ndash;109, &sect;6, Jan. 4, 2002, 115 Stat. 1414; Pub. L. 110&ndash;85, title III, &sect;306(a), Sept. 27, 2007, 121 Stat. 864.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:codification-note -->
<h4 class="note-head">Codification</h4>
<p class="note-body">Section was enacted as part of the Best Pharmaceuticals for Children Act, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter.</p>
<!-- field-end:codification-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">2007&mdash;Subsec. (b). Pub. L. 110&ndash;85 inserted &ldquo;,&nbsp;including increasing pediatric access to medical devices&rdquo; before period at end.</p>
<!-- field-end:amendment-note -->
<!-- field-end:notes -->

<!-- documentid:21_394  usckey:210000000039400000000000000000000 currentthrough:20080108 documentPDFPage:363 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 394 -->
<!-- itemsortkey:210AALP -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 394 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;394. Scientific review groups</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">Without regard to the provisions of title 5 governing appointments in the competitive service and without regard to the provisions of chapter 51 and subchapter III of chapter 53 of such title relating to classification and General Schedule pay rates, the Commissioner of Food and Drugs may&mdash;</p>
<p class="statutory-body-1em">(1) establish such technical and scientific review groups as are needed to carry out the functions of the Food and Drug Administration (including functions prescribed under this chapter); and</p>
<p class="statutory-body-1em">(2) appoint and pay the members of such groups, except that officers and employees of the United States shall not receive additional compensation for service as members of such groups.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;904, formerly &sect;903, as added Pub. L. 101&ndash;635, title III, &sect;301, Nov. 28, 1990, 104 Stat. 4584; renumbered &sect;904, Pub. L. 103&ndash;43, title XX, &sect;2006(1), June 10, 1993, 107 Stat. 209.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The provisions of title 5 governing appointments in the competitive service, referred to in text, are classified generally to section 3301 et seq. of Title 5, Government Organization and Employees.</p>
<!-- field-end:referenceintext-note -->
<!-- field-end:notes -->

<!-- documentid:21_395  usckey:210000000039500000000000000000000 currentthrough:20080108 documentPDFPage:363 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 395 -->
<!-- itemsortkey:210AALQ -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 395 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;395. Loan repayment program</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<h4 class="paragraph-head">(1) Authority for program</h4>
<p class="statutory-body-1em">Subject to paragraph (2), the Secretary shall carry out a program of entering into contracts with appropriately qualified health professionals under which such health professionals agree to conduct research, as employees of the Food and Drug Administration, in consideration of the Federal Government agreeing to repay, for each year of such service, not more than $20,000 of the principal and interest of the educational loans of such health professionals.</p>
<h4 class="paragraph-head">(2) Limitation</h4>
<p class="statutory-body-1em">The Secretary may not enter into an agreement with a health professional pursuant to paragraph (1) unless such professional&mdash;</p>
<p class="statutory-body-2em">(A) has a substantial amount of educational loans relative to income; and</p>
<p class="statutory-body-2em">(B) agrees to serve as an employee of the Food and Drug Administration for purposes of paragraph (1) for a period of not less than 3 years.</p>
<h4 class="subsection-head">(b) Applicability of certain provisions</h4>
<p class="statutory-body">With respect to the National Health Service Corps Loan Repayment Program established in subpart III of part D of title III of the Public Health Service Act [42 U.S.C. 254<em>l</em> et seq.], the provisions of such subpart shall, except as inconsistent with subsection (a) of this section, apply to the program established in such subsection in the same manner and to the same extent as such provisions apply to the National Health Service Corps Loan Repayment Program.</p>
<h4 class="subsection-head">(c) Authorization of appropriations</h4>
<p class="statutory-body">For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 1994 through 1996.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;905, as added Pub. L. 103&ndash;43, title XX, &sect;2006(2), June 10, 1993, 107 Stat. 210.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The Public Health Service Act, referred to in subsec. (b), is act July 1, 1944, ch. 373, 58 Stat. 682, as amended. Subpart III of part D of title III of the Act is classified generally to subpart III [&sect;254<em>l</em> et seq.] of part D of subchapter II of chapter 6A of Title 42, The Public Health and Welfare. For complete classification of this Act to the Code, see Short Title note set out under section 201 of Title 42 and Tables.</p>
<!-- field-end:referenceintext-note -->
<!-- field-end:notes -->

<!-- documentid:21_396  usckey:210000000039600000000000000000000 currentthrough:20080108 documentPDFPage:363 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 396 -->
<!-- itemsortkey:210AALR -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 396 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;396. Practice of medicine</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<p class="statutory-body">Nothing in this chapter shall be construed to limit or interfere with the authority of a health care practitioner to prescribe or administer any legally marketed device to a patient for any condition or disease within a legitimate health care practitioner-patient relationship. This section shall not limit any existing authority of the Secretary to establish and enforce restrictions on the sale or distribution, or in the labeling, of a device that are part of a determination of substantial equivalence, established as a con<!-- PDFPage:364 -->dition of approval, or promulgated through regulations. Further, this section shall not change any existing prohibition on the promotion of unapproved uses of legally marketed devices.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;906, as added Pub. L. 105&ndash;115, title II, &sect;214, Nov. 21, 1997, 111 Stat. 2348.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:effectivedate-note -->
<h4 class="note-head">Effective Date</h4>
<p class="note-body">Section effective 90 days after Nov. 21, 1997, except as otherwise provided, see section 501 of Pub. L. 105&ndash;115, set out as an Effective Date of 1997 Amendment note under section 321 of this title.</p>
<!-- field-end:effectivedate-note -->
<!-- field-end:notes -->

<!-- documentid:21_397  usckey:210000000039700000000000000000000 currentthrough:20080108 documentPDFPage:364 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 397 -->
<!-- itemsortkey:210AALS -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 397 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;397. Contracts for expert review</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<h4 class="paragraph-head">(1) Authority</h4>
<p class="statutory-body-1em">The Secretary may enter into a contract with any organization or any individual (who is not an employee of the Department) with relevant expertise, to review and evaluate, for the purpose of making recommendations to the Secretary on, part or all of any application or submission (including a petition, notification, and any other similar form of request) made under this chapter for the approval or classification of an article or made under section 351(a) of the Public Health Service Act (42 U.S.C. 262(a)) with respect to a biological product. Any such contract shall be subject to the requirements of section 379 of this title relating to the confidentiality of information.</p>
<h4 class="paragraph-head">(2) Increased efficiency and expertise through contracts</h4>
<p class="statutory-body-1em">The Secretary may use the authority granted in paragraph (1) whenever the Secretary determines that use of a contract described in paragraph (1) will improve the timeliness of the review of an application or submission described in paragraph (1), unless using such authority would reduce the quality, or unduly increase the cost, of such review. The Secretary may use such authority whenever the Secretary determines that use of such a contract will improve the quality of the review of an application or submission described in paragraph (1), unless using such authority would unduly increase the cost of such review. Such improvement in timeliness or quality may include providing the Secretary increased scientific or technical expertise that is necessary to review or evaluate new therapies and technologies.</p>
<h4 class="subsection-head">(b) Review of expert review</h4>
<h4 class="paragraph-head">(1) In general</h4>
<p class="statutory-body-1em">Subject to paragraph (2), the official of the Food and Drug Administration responsible for any matter for which expert review is used pursuant to subsection (a) of this section shall review the recommendations of the organization or individual who conducted the expert review and shall make a final decision regarding the matter in a timely manner.</p>
<h4 class="paragraph-head">(2) Limitation</h4>
<p class="statutory-body-1em">A final decision by the Secretary on any such application or submission shall be made within the applicable prescribed time period for review of the matter as set forth in this chapter or in the Public Health Service Act (42 U.S.C. 201 et seq.).</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;907, as added Pub. L. 105&ndash;115, title IV, &sect;415, Nov. 21, 1997, 111 Stat. 2377.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">The Public Health Service Act, referred to in subsec. (b)(2), is act July 1, 1944, ch. 373, 58 Stat. 682, as amended, which is classified generally to chapter 6A (&sect;201 et seq.) of Title 42, The Public Health and Welfare. For complete classification of this Act to the Code, see Short Title note set out under section 201 of Title 42 and Tables.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:effectivedate-note -->
<h4 class="note-head">Effective Date</h4>
<p class="note-body">Section effective 90 days after Nov. 21, 1997, except as otherwise provided, see section 501 of Pub. L. 105&ndash;115, set out as an Effective Date of 1997 Amendment note under section 321 of this title.</p>
<!-- field-end:effectivedate-note -->
<!-- field-end:notes -->

<!-- documentid:21_398  usckey:210000000039800000000000000000000 currentthrough:20080108 documentPDFPage:364 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 398 -->
<!-- itemsortkey:210AALT -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 398 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;398. Notices to States regarding imported food</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">If the Secretary has credible evidence or information indicating that a shipment of imported food or portion thereof presents a threat of serious adverse health consequences or death to humans or animals, the Secretary shall provide notice regarding such threat to the States in which the food is held or will be held, and to the States in which the manufacturer, packer, or distributor of the food is located, to the extent that the Secretary has knowledge of which States are so involved. In providing notice to a State, the Secretary shall request the State to take such action as the State considers appropriate, if any, to protect the public health regarding the food involved.</p>
<h4 class="subsection-head">(b) Rule of construction</h4>
<p class="statutory-body">Subsection (a) of this section may not be construed as limiting the authority of the Secretary with respect to food under any other provision of this chapter.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;908, as added Pub. L. 107&ndash;188, title III, &sect;310, June 12, 2002, 116 Stat. 673.)</p>
<!-- field-end:sourcecredit -->

<!-- documentid:21_399  usckey:210000000039900000000000000000000 currentthrough:20080108 documentPDFPage:364 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 399 -->
<!-- itemsortkey:210AALU -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 399 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;399. Grants to States for inspections</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) In general</h4>
<p class="statutory-body">The Secretary is authorized to make grants to States, territories, and Indian tribes (as defined in section 450b(e) of title 25) that undertake examinations, inspections, and investigations, and related activities under section 372 of this title. The funds provided under such grants shall only be available for the costs of conducting such examinations, inspections, investigations, and related activities.</p>
<h4 class="subsection-head">(b) Notices regarding adulterated imported food</h4>
<p class="statutory-body">The Secretary may make grants to the States for the purpose of assisting the States with the costs of taking appropriate action to protect the public health in response to notification under section 398 of this title, including planning and otherwise preparing to take such action.</p>
<h4 class="subsection-head">(c) Authorization of appropriations</h4>
<p class="statutory-body">For the purpose of carrying out this section, there are authorized to be appropriated <!-- PDFPage:365 -->$10,000,000 for fiscal year 2002, and such sums as may be necessary for each of the fiscal years 2003 through 2006.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;909, as added Pub. L. 107&ndash;188, title III, &sect;311, June 12, 2002, 116 Stat. 673.)</p>
<!-- field-end:sourcecredit -->

<!-- documentid:21_399a  usckey:210000000039900000000000a00000000 currentthrough:20080108 documentPDFPage:365 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER IX/Sec. 399a -->
<!-- itemsortkey:210AALV -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER IX-MISCELLANEOUS!@!Sec. 399a -->
<!-- field-start:head -->
<h3 class="section-head">&sect;399a. Office of the Chief Scientist</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Establishment; appointment</h4>
<p class="statutory-body">The Secretary shall establish within the Office of the Commissioner an office to be known as the Office of the Chief Scientist. The Secretary shall appoint a Chief Scientist to lead such Office.</p>
<h4 class="subsection-head">(b) Duties of the Office</h4>
<p class="statutory-body">The Office of the Chief Scientist shall&mdash;</p>
<p class="statutory-body-1em">(1) oversee, coordinate, and ensure quality and regulatory focus of the intramural research programs of the Food and Drug Administration;</p>
<p class="statutory-body-1em">(2) track and, to the extent necessary, coordinate intramural research awards made by each center of the Administration or science-based office within the Office of the Commissioner, and ensure that there is no duplication of research efforts supported by the Reagan-Udall Foundation for the Food and Drug Administration;</p>
<p class="statutory-body-1em">(3) develop and advocate for a budget to support intramural research;</p>
<p class="statutory-body-1em">(4) develop a peer review process by which intramural research can be evaluated;</p>
<p class="statutory-body-1em">(5) identify and solicit intramural research proposals from across the Food and Drug Administration through an advisory board composed of employees of the Administration that shall include&mdash;</p>
<p class="statutory-body-2em">(A) representatives of each of the centers and the science-based offices within the Office of the Commissioner; and</p>
<p class="statutory-body-2em">(B) experts on trial design, epidemiology, demographics, pharmacovigilance, basic science, and public health; and</p>
<br class="Q04" />
<p class="statutory-body-1em">(6) develop postmarket safety performance measures that are as measurable and rigorous as the ones already developed for premarket review.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;910, as added Pub. L. 110&ndash;85, title VI, &sect;602, Sept. 27, 2007, 121 Stat. 898.)</p>
<!-- field-end:sourcecredit -->


</body></html>